Skip to main content

NUEVOS METODOS PARA EL CULTIVO Y CARACTERIZACION DE PROBIOTICOS DE PROXIMA GENERACION CON POTENCIAL APLICACION EN LA ENFERMEDAD INFLAMATORIA INTESTINAL

AGL2016-78311-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 32
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Novel methods of microbiome analysis in the food industry

  • Sabater, Carlos
  • Cobo Díaz, José Francisco
  • Álvarez Ordóñez, Avelino
  • Ruas Madiedo, Patricia
  • Ruiz, Lorena
  • Margolles, Abelardo
[EN]The study of the food microbiome has gained considerable interest in recent years, mainly due to the wide range of applications that can be derived from the analysis of metagenomes. Among these applications, it is worth mentioning the possibility of using metagenomic analyses to determine food authenticity, to assess the microbiological safety of foods thanks to the detection and tracking of pathogens, antibiotic resistance genes and other undesirable traits, as well to identify the microorganisms responsible for food processing defects. Metataxonomics and metagenomics are currently the gold standard methodologies to explore the full potential of metagenomes in the food industry. However, there are still a number of challenges that must be solved in order to implement these methods routinely in food chain monitoring, and for the regulatory agencies to take them into account in their opinions. These challenges include the difficulties of analysing foods and food-related environments with a low microbial load, the lack of validated bioinformatics pipelines adapted to food microbiomes and the difficulty of assessing the viability of the detected microorganisms. This review summarizes the methods of microbiome analysis that have been used, so far, in foods and food-related environments, with a specific focus on those involving Next-Generation Sequencing technologies., SI, The work in our research groups was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 818368 (MASTER), and the grants RTI2018-095021-J-I00 (funded by (MCIU/AEI/FEDER, UE), AGL2016-78085-P and AGL2016-78311-R (funded by (MINECO/AEI/FEDER, UE). Carlos Sabater acknowledges his Postdoctoral research contract funded by the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) and Postdoctoral research contract Juan de la Cierva-Formación from Spanish Ministry of Science and Innovation (FJC2019-042125-I).
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

In silico approach for unveiling the glycoside hydrolase activities in faecalibacterium prausnitzii through a systematic and integrative large-scale analysis

  • Blanco Gonzalez, Guillermo
  • Sanchez Garcia, Borja
  • Fernández Riverola, Florentino
  • Margolles, Abelardo
  • GARCIA LOURENÇO, Analia Maria
This work presents a novel in silico approach to the prediction and characterization of the glycolytic capacities of the beneficial intestinal bacterium Faecalibacterium prausnitzii. Available F. prausnitzii genomes were explored taking the glycolytic capacities of F. prausnitzii SL3/3 and F. prausnitzii L2-6 as reference. The comparison of the generated glycolytic profiles offered insights into the particular capabilities of F. prausnitzii SL3/3 and F. prausnitzii L2-6 as well as the potential of the rest of strains. Glycoside hydrolases were mostly detected in the pathways responsible for the starch and sucrose metabolism and the biosynthesis of secondary metabolites, but this analysis also identified some other potentially interesting, but still uncharacterized activities, such as several hexosyltransferases and some hydrolases. Gene neighborhood maps offered additional understanding of the genes coding for relevant glycoside hydrolases. Although information about the carbohydrate preferences of F. prausnitzii is scarce, the in silico metabolic predictions were consistent with previous knowledge about the impact of fermentable sugars on the growth promotion and metabolism of F. prausnitzii. So, while the predictions still need to be validated using culturing methods, the approach holds the potential to be reproduced and scaled to accommodate the analysis of other strains (or even families and genus) as well as other metabolic activities. This will allow the exploration of novel methodologies to design or obtain targeted probiotics for F. prausnitzii and other strains of interest., Fundação para a Ciência e a Tecnologia | Ref. UID/BIO/04469/2013, Fundação para a Ciência e a Tecnologia | Ref. COMPETE 2020 (POCI-01-0145-FEDER006684), Agencia Estatal de Investigación | Ref. AGL2016-78311-R, Xunta de Galicia | Ref. ED431C2018/55-GRC
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

Computational approach to the systematic prediction of glycolytic abilities: looking into human microbiota

  • Blanco Gonzalez, Guillermo
  • Sanchez Garcia, Borja
  • Ruiz, Lorena
  • Fernández Riverola, Florentino
  • Margolles, Abelardo
  • GARCIA LOURENÇO, Analia Maria
Glycoside hydrolases are responsible for the enzymatic deconstruction of complex carbohydrates. Most of the families are known to conserve the catalytic machinery and molecular mechanisms. This work introduces a new method to predict glycolytic abilities in sequenced genomes and thus, gain a better understanding of how to target specific carbohydrates and identify potentially interesting sources of specialised enzymes. Genome sequences are aligned to those of organisms with expertly curated glycolytic abilities. Clustering of homology scores helps identify organisms that share common abilities and the most promising organisms regarding specific glycolytic abilities. The method has been applied to members of the bacterial families Ruminococcaceae (39 genera), Eubacteriaceae (11 genera) and Lachnospiraceae (59 genera), which hold major representatives of the human gut microbiota. The method predicted the potential presence of glycoside hydrolases in 1701 species of these genera. Here, the validity and practical usefulness of the method is discussed based on the predictions obtained for members of the genus Ruminococcus. Results were consistent with existing literature and offer useful, complementary insights to comparative genomics and physiological testing. The implementation of the Gleukos web portal (http://sing-group.org/ gleukos) offers a public service to those interested in targeting microbial carbohydrate metabolism for biotechnological and health applications., Agencia Estatal de Investigación | Ref. AGL2016-78311-R, Principado de Asturias | Ref. IDI/2018/000236
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

In silico and functional analyses of immunomodulatory peptides encrypted in the human gut metaproteome

  • Cambeiro Pérez, Noelia
  • Hidalgo Cantabrana, Claudio
  • Moro García, Marco Antonio
  • Blanco Míguez, Aitor
  • Fernández Riverola, Florentino
  • Riestra, Sabino
  • GARCIA LOURENÇO, Analia Maria
  • Alonso Arias, Rebeca
  • Margolles, Abelardo
  • Martínez Carballo, Elena
  • Sanchez Garcia, Borja
This work supports the massive presence of potential immunomodulatory peptides in the human gut metaproteome. These peptides were identified through the MAHMI database as potentially anti-inflammatory, and sixteen of them synthesized for characterize their mechanism of action. From them, peptide HM14 was encrypted in an extracellular protein produced by Bifidobacterium longum, a common member of the human microbiota, and displayed the highest anti-inflammatory capability. Molecular mechanism of action of HM14 pointed to a specific interaction between this immunomodulatory peptide and antigen presenting cells, which resulted in a higher formation of iTreg cells. Moreover, HM14 was effective in decreasing pro-inflammatory parameters in PBMCs isolated from a cohort of Crohn's patients. Finally, non-targeted metabolomics confirmed the ability of HM14 to modulate the metabolic activity of PBMCs to fulfil its energy and biosynthetic requirements. Overall, our combined in silico/multiomics approach supports the human gut metaproteome as a source for immunomodulatory peptides., Ministerio de Economía y Competitividad | Ref. AGL2013-44761-P, Agencia Estatal de Investigación | Ref. AGL2016-78311-R
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

Revisiting the metabolic capabilities of bifidobacterium longum susbp. longum and bifidobacterium longum subsp. infantis from a glycoside hydrolase perspective

  • Blanco Gonzalez, Guillermo
  • Ruiz, Lorena
  • Tamés, Héctor
  • Ruas Madiedo, Patricia
  • Fernández Riverola, Florentino
  • Sanchez Garcia, Borja
  • GARCIA LOURENÇO, Analia Maria
  • Margolles, Abelardo
Bifidobacteria are among the most abundant microorganisms inhabiting the intestine of humans and many animals. Within the genus Bifidobacterium, several beneficial effects have been attributed to strains belonging to the subspecies Bifidobacterium longum subsp. longum and Bifidobacterium longum subsp. infantis, which are often found in infants and adults. The increasing numbers of sequenced genomes belonging to these two subspecies, and the availability of novel computational tools focused on predicting glycolytic abilities, with the aim of understanding the capabilities of degrading specific carbohydrates, allowed us to depict the potential glycoside hydrolases (GH) of these bacteria, with a focus on those GH profiles that differ in the two subspecies. We performed an in silico examination of 188 sequenced B. longum genomes and depicted the commonly present and strain-specific GHs and GH families among representatives of this species. Additionally, GH profiling, genome-based and 16S rRNA-based clustering analyses showed that the subspecies assignment of some strains does not properly match with their genetic background. Furthermore, the analysis of the potential GH component allowed the distinction of clear GH patterns. Some of the GH activities, and their link with the two subspecies under study, are further discussed. Overall, our in silico analysis poses some questions about the suitability of considering the GH activities of B. longum subsp. longum and B. longum subsp. infantis to gain insight into the characterization and classification of these two subspecies with probiotic interest., Agencia Estatal de Investigación | Ref. AGL2016-78311-R, Agencia Estatal de Investigación | Ref. RTI2018-095021-J-I00, Principado de Asturias | Ref. IDI/2018/000236, Xunta de Galicia | Ref. ED431C2018/55, Xunta de Galicia | Ref. ED431G2019/06, Fundação para a Ciência e a Tecnologia | Ref. UIDB /04469/2020
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

DEWE: A novel tool for executing differential expression RNA-Seq workflows in biomedical research

  • López Fernández, Hugo
  • Blanco Míguez, Aitor
  • Fernández Riverola, Florentino
  • Sanchez Garcia, Borja
  • GARCIA LOURENÇO, Analia Maria
Background: Transcriptomics profiling aims to identify and quantify all transcripts present within a cell type or tissue at a particular state, and thus provide information on the genes expressed in specific experimental settings, differentiation or disease conditions. RNA-Seq technology is becoming the standard approach for such studies, but available analysis tools are often hard to install, configure and use by users without advanced bioinformatics skills. Methods: Within reason, DEWE aims to make RNA-Seq analysis as easy for non-proficient users as for experienced bioinformaticians. DEWE supports two well-established and widely used differential expression analysis workflows: using Bowtie2 or HISAT2 for sequence alignment; and, both applying StringTie for quantification, and Ballgown and edgeR for differential expression analysis. Also, it enables the tailored execution of individual tools as well as helps with the management and visualisation of differential expression results. Results: DEWE provides a user-friendly interface designed to reduce the learning curve of less knowledgeable users while enabling analysis customisation and software extension by advanced users. Docker technology helps overcome installation and configuration hurdles. In addition, DEWE produces high quality and publication-ready outputs in the form of tab-delimited files and figures, as well as helps researchers with further analyses, such as pathway enrichment analysis. Conclusions: The abilities of DEWE are exemplified here by practical application to a comparative analysis of monocytes and monocyte-derived dendritic cells, a study of clinical relevance. DEWE installers and documentation are freely available at https://www.sing-group.org/dewe., Ministerio de Economía y Competitividad | Ref. AGL2013-44039R, Xunta de Galicia | Ref. ED431C2018 / 55-GRC, Fundação para a Ciência e a Tecnologia | Ref. UID/BIO/04469/2019, Agencia Estatal de Investigación | Ref. AGL2016-78311-R
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In silico prediction reveals the existence of potential bioactive neuropeptides produced by the human gut microbiota

  • Blanco-Míguez, Aitor
  • Fdez-Riverola, Florentino
  • Lourenço, Anália
  • Sánchez García, Borja
This work reports on a large-scale potential neuropeptide activity screening in human gut microbiomes deposited in public databases. In our experimental approach, the sequences of the bioactive peptides collected in the MAHMI database, mainly predicted as immunomodulatory or antitumoral, were crossed with those of the neuroactive/digestive peptides. From 91,325,790 potential bioactive peptides, only 581 returned a match when crossed against the 5949 neuroactive peptides from the NeuroPep database and the 15 digestive hormones. Relevant bacterial taxa, such as Ruminococcus sp., Clostridium sp. were found among the main producers of the matching sequences, and many of the matches corresponded to adiponectin and the hormone produced by adipocites, which is involved in glucose homeostasis. These results show, for the first time, the presence of potentially bioactive peptides produced by gut microbiota members over the nervous cells, most notably, peptides with already predicted immunomodulatory or anti-inflammatory activity. Classical (Lactobacillus sp.) and next-generation (Faecalibacterium sp.) probiotics are shown to produce these peptides, which are proposed as a potential mechanism of action of psychobiotics. Our previous experimental results showed that many of these peptides were active when incubated with immune cells, such as dendritic cells, so their effect over the nervous system innervating the gut mucosa holds significant potential and should be explored., This work was supported by the Spanish “Programa Estatal de Investigación, Desarrollo e Inovación Orientada a los Retos de la Sociedad” (Grant AGL2016-78311-R); the Asociación Española Contra el Cancer (“Obtención de péptidos bioactivos contra el Cáncer Colo-Rectal a partir de secuencias genéticas de microbiomas intestinales”, grant PS-2016). This study was also supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER006684). SING group thanks CITI (Centro de Investigación, Transferencia e Innovación) from University of Vigo for hosting its IT infrastructure. This work was partially supported by the Asturias Regional Plan I+D+i for research groups (FYCYT-IDI/2018/000236) and by the Consellería de Educación, Universidades e Formación Profesional (Xunta de Galicia) under the scope of the strategic funding of ED431C2018/55-GRC Competitive Reference Group., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Bifidobacteria and their molecular communication with the immune system

  • Ruíz García, Lorena
  • Delgado, Susana
  • Ruas-Madiedo, Patricia
  • Sánchez García, Borja
  • Margolles Barros, Abelardo
Bifidobacterium represents a genus within the phylum Actinobacteria which is one of the major phyla in the healthy intestinal tract of humans. Bifidobacterium is one of the most abundant genera in adults, but its predominance is even more pronounced in infants, especially during lactation, when they can constitute the majority of the total bacterial population. They are one of the pioneering colonizers of the early gut microbiota, and they are known to play important roles in the metabolism of dietary components, otherwise indigestible in the upper parts of the intestine, and in the maturation of the immune system. Bifidobacteria have been shown to interact with human immune cells and to modulate specific pathways, involving innate and adaptive immune processes. In this mini-review, we provide an overview of the current knowledge on the immunomodulatory properties of bifidobacteria and the mechanisms and molecular players underlying these processes, focusing on the corresponding implications for human health. We deal with in vitro models suitable for studying strain-specific immunomodulatory activities. These include peripheral blood mononuclear cells and T cell-mediated immune responses, both effector and regulatory cell responses, as well as the modulation of the phenotype of dendritic cells, among others. Furthermore, preclinical studies, mainly germ-free, gnotobiotic, and conventional murine models, and human clinical trials, are also discussed. Finally, we highlight evidence supporting the immunomodulatory effects of bifidobacterial molecules (proteins and peptides, exopolysaccharides, metabolites, and DNA), as well as the role of bifidobacterial metabolism in maintaining immune homeostasis through cross-feeding mechanisms., LR is a postdoctoral researcher supported by the Juan de la Cierva Postdoctoral Trainee Program of the Spanish Ministry of Economy and Competitiveness (MINECO; IJCI-2015-23196). BS and AM thanks MINECO for the funding of the project AGL2016-78311-R and PR-M for the project AGL2015-64901-R. SD is supported by a research contract associated to the project BIO2014-55019-JIN from the Spanish “Plan Estatal de I+D+i”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Fecal Microbiota transplantation: Historical perspective and future trends

  • Margolles Barros, Abelardo
  • Sánchez García, Borja
  • Ruas-Madiedo, Patricia
  • Delgado, Susana
  • Ruíz García, Lorena
Trabajo presentado en el 10th Workshop on Probiotics and Prebiotics, de la Sociedad Española de Probióticos y Prebióticos (SEPyP), celebrado en Las Palmas de Gran Canarias, del 6 al 8 de febrero de 2019, The human gut microbiota is composed of the different microorganisms of our intestinal ecosystem. It has an important metabolic and nutritional role, and it is involved in the correct development of the gut and the maturation of our immune system. Currently, the application of fecal microbiota transplantation (FMT) has allowed us to establish causality in microbiome studies, and we know that microbiota can cure diseases or induce the appearance of disease symptoms, or even determine the success of some health treatments. But knowledge of the curative effects of feces has been documented many centuries ago. In the present article we want to make a brief review of the history of FMT, focusing on its effect on the human microbiome and its capacity to act on human physiology. We also want to place special emphasis on aspects that must be taken into account to translate microbiome research to medicine, related to safety, regulation and standardization of methods, as well as the importance of being able to predict the success of FMT., Research in our group is funded by grants BIO2014-55019-JIN and AGL2016-78311-R (from the Spanish Ministry of Economy and Competitiveness) and a grant from the Asociación Española contra el Cáncer (Reference: PS2016). Lorena Ruiz is the recipient of a Juan de la Cierva Post-Doctoral contract (IJCI-2015-23196) from the Spanish Ministry of Economy and Competitiveness
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecules Produced by Probiotics and Intestinal Microorganisms with Immunomodulatory Activity

  • Delgado, Susana
  • Sánchez García, Borja
  • Margolles Barros, Abelardo
  • Ruas-Madiedo, Patricia
  • Ruíz García, Lorena
© 2020 by the authors., Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. The probiotic microorganisms most commonly used in the food and pharmacy industry belong to Lactobacillus and Bifidobacterium, and several strains of these genera have demonstrated beneficial attributes. In addition, some other intestinal bacteria inhabiting the human microbiota, such as Faecalibacterium prausnitzii and Akkermansia muciniphila, have recently been discovered and are able to display health-promoting effects in animal and human trials. The beneficial properties of probiotics have been known for a long time, although little is known about the molecular mechanisms and the molecules responsible for their effects. However, in recent years, advances in microbiome studies, and the use of novel analytical and molecular techniques have allowed a deeper insight into their effects at the molecular level. This review summarizes the current knowledge of some of the molecules of probiotics and other intestinal commensal bacteria responsible for their immunomodulatory effect, focusing on those with more solid scientific evidence., Funding in our group is supported by the grants IDI/2018/000236 from the Principality of Asturias, AGL2016-78311-R (AEI/FEDER UE) from the Ministry of Economy and Competitiveness (MINECO), and RTI2018-096339-B-I00 and RTI2018-095021-J-I00 (MCIU/AEI/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In silico approach for unveiling the Glycoside Hydrolase activities in Faecalibacterium prausnitzii through a systematic and integrative large-scale analysis

  • Blanco González, Guillermo
  • Sánchez García, Borja
  • Fdez-Riverola, Florentino
  • Margolles Barros, Abelardo
  • Lourenço, Anália
This work presents a novel in silico approach to the prediction and characterization of the glycolytic capacities of the beneficial intestinal bacterium Faecalibacterium prausnitzii. Available F. prausnitzii genomes were explored taking the glycolytic capacities of F. prausnitzii SL3/3 and F. prausnitzii L2-6 as reference. The comparison of the generated glycolytic profiles offered insights into the particular capabilities of F. prausnitzii SL3/3 and F. prausnitzii L2-6 as well as the potential of the rest of strains. Glycoside hydrolases were mostly detected in the pathways responsible for the starch and sucrose metabolism and the biosynthesis of secondary metabolites, but this analysis also identified some other potentially interesting, but still uncharacterized activities, such as several hexosyltransferases and some hydrolases. Gene neighborhood maps offered additional understanding of the genes coding for relevant glycoside hydrolases. Although information about the carbohydrate preferences of F. prausnitzii is scarce, the in silico metabolic predictions were consistent with previous knowledge about the impact of fermentable sugars on the growth promotion and metabolism of F. prausnitzii. So, while the predictions still need to be validated using culturing methods, the approach holds the potential to be reproduced and scaled to accommodate the analysis of other strains (or even families and genus) as well as other metabolic activities. This will allow the exploration of novel methodologies to design or obtain targeted probiotics for F. prausnitzii and other strains of interest., This work was supported by the Spanish “Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad” (Grant AGL2016-78311-R); and, the Asociación Española Contra el Cáncer (“Obtención de péptidos bioactivos contra el Cáncer Colo-Rectal a partir de secuencias genéticas de microbiomas intestinales,” Grant PS-2016). This work was also supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI01-0145-FEDER006684). This work was partially supported by the Consellería de Educación, Universidades e Formación Profesional (Xunta de Galicia) under the scope of the strategic funding of ED431C2018/55-GRC Competitive Reference Group
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Las proteínas extracelulares de Lactobacillus acidophilus DSM 20079T como potenciales moduladores de la respuesta inmune en enfermedades inflamatorias crónicas

  • Blanco-Míguez, Aitor
  • Hidalgo-Cantabrana, Claudio
  • Moro-García, Marco A.
  • Fdez-Riverola, Florentino
  • Oliván, Mamen
  • Royo, Luis
  • Riestra, Sabino
  • Mayo Pérez, Baltasar
  • Lourenço, Anália
  • Alonso, Rebeca
  • Sánchez García, Borja
Trabajo presentado en la 13ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Madrid (España) del 17 al 18 de junio de 2019, El uso de probióticos o compuestos bacterianos se ha propuesto como un mecanismo para modular la respuesta inmune del hospedador y remodelar el microbioma humano. Sin embargo, actualmente existe una falta de información sobre las vías moleculares inducidas por las bacterias probióticas, o sobre la interacción entre los probióticos y el sistema inmunológico. Lactobacillus es un género del filo Firmicutes que incluye cepas probióticas y representativas de la microbiota gastrointestinal humana. Estudios independientes han demostrado las propiedades antiinflamatorias de diferentes cepas de Lactobacillus, aunque estamos lejos de comprender la interacción molecular subyacente. En este trabajo, demostramos que una administración diaria de 5e10 células viables de Lactobacillus acidophilus DSM 20079T (DSM20079) a lechones sanos produjo un aumento plasmático de la interleucina antinflamatoria IL10, disminuyendo, a su vez, la interleucina IL12 y la ratio proinflamatorio IL12 + TNF α / IL10. Además, las células mononucleares de sangre preriféricas (PBMCs) extraídas de estos lechones se volvieron menos reactivas contra el lipopolisacárido de Escherichia coli (LPS) y la fitohemaglutinina de Phaseolus vulgaris (PHA), cuando se ven afectadas por la cepa DSM20079. Se identificó la fracción proteica extracelular de DSM20079 como la responsable de esta modulación. El efecto tolerogénico ejercido por las proteínas extracelulares de esta cepa sugiere su uso potencial como coadyuvante para aplicaciones terapéuticas dirigidas a enfermedades inflamatorias crónicas., Este trabajo fue respaldado por el >Programa Estatal de Investigación, Desarrollo e Inovación Orientada a los Retos de la Sociedad> (AGL2016-78311- R); la Asociación Española Contra el Cáncer (>Obtención de péptidos bioactivos contra el Cáncer Colo-Rectal a partir de secuencias genéticas de microbiomas intestinales>, PS-2016).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Modificación dirigida de la microbiota intestinal utilizando un anticuerpo policlonal contra la capa S de Lactobacillus acidophilus DSM20079T

  • Marcos-Fernández, Raquel
  • Ruíz García, Lorena
  • Blanco-Míguez, Aitor
  • Margolles Barros, Abelardo
  • Sánchez García, Borja
Trabajo presentado en la 13ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Madrid (España) del 17 al 18 de junio de 2019, Durante los últimos diez años ha habido avances en la compresión de cómo la microbiota intestinal humana contribuye a nuestra salud y enfermedad. La microbiota humana, especialmente la microbiota intestinal, es considerada un “órgano esencial” debido a que las comunidades microbianas que colonizan todas las superficies de nuestro cuerpo nos proporcionan funciones metabólicas, inmunológicas y fisiológicas esenciales. Tras el nacimiento, nuestra microbiota intestinal alcanza su configuración final a la edad de 2 a 3 años con la introducción de alimentos sólidos, estableciéndose una comunidad de microorganismos dominada por anaerobios obligados. Después del nacimiento, alrededor de 100 especies bacterianas colonizan el intestino, aumentando hasta 103 en la edad adulta. Su composición evoluciona constantemente, dependiendo de factores internos y externos como la edad, la raza, la dieta, la colonización materna, así como la exposición a antibióticos y xenobióticos. Además, otros factores como el estrés o los tratamientos farmacológicos conducen a rápidos cambios en la composición de nuestra microbiota. La complejidad de la microbiota intestinal hace difícil deducir la contribución individual de una especie/cepa a un fenotipo, enfermedad o condición. Por ello, el desarrollo de métodos para la modificación dirigida de una microbiota, especialmente enfocada en eliminar de una comunidad microbiana una bacteria específica, podría ser útil para descifrar como una especie contribuye a una enfermedad o a un proceso fisiológico, inmunológico o metabólico. En este estudio presentamos una tecnología que, si bien no es desconocida, sí que es pionera en cuanto a su aplicación. Hemos utilizado un anticuerpo policlonal dirigido a la proteína A de la capa S de Lactobacillus acidophilus DSM20079T para conseguir detectarlo en un consorcio bacteriano compuesto de 8 especies representativas de la microbiota intestinal humana. Además, se ha realizado una depleción y enriquecimiento positivo (y por lo tanto un aislamiento de esta bacteria del resto de especies microbianas) tanto en una microbiota sintética como en microbiotas reales. La depleción de L. acidophilus del resto de especies se realiza en un solo paso, mientras que para el enriquecimiento positivo de esta especie fue necesario el uso de tripsina ya que L. acidophilus interacciona con otras bacterias de su entorno a través de interacciones proteínaproteína u otros potenciales receptores presentes en bacterias como Akkermansia muciniphila. Esta técnica contribuirá a comprender las contribuciones específicas de una sola bacteria dentro de una microbiota intestinal humana compleja., AGL2016-78311-R
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Revisiting the Metabolic Capabilities of Bifidobacterium longum susbp. longum and Bifidobacterium longum subsp. infantis from a Glycoside Hydrolase Perspective

  • Blanco González, Guillermo
  • Ruíz García, Lorena
  • Tamés, Hector
  • Ruas-Madiedo, Patricia
  • Fdez-Riverola, Florentino
  • Sánchez García, Borja
  • Lourenço, Anália
  • Margolles Barros, Abelardo
© 2020 by the authors., Bifidobacteria are among the most abundant microorganisms inhabiting the intestine of humans and many animals. Within the genus Bifidobacterium, several beneficial effects have been attributed to strains belonging to the subspecies Bifidobacterium longum subsp. longum and Bifidobacterium longum subsp. infantis, which are often found in infants and adults. The increasing numbers of sequenced genomes belonging to these two subspecies, and the availability of novel computational tools focused on predicting glycolytic abilities, with the aim of understanding the capabilities of degrading specific carbohydrates, allowed us to depict the potential glycoside hydrolases (GH) of these bacteria, with a focus on those GH profiles that differ in the two subspecies. We performed an in silico examination of 188 sequenced B. longum genomes and depicted the commonly present and strain-specific GHs and GH families among representatives of this species. Additionally, GH profiling, genome-based and 16S rRNA-based clustering analyses showed that the subspecies assignment of some strains does not properly match with their genetic background. Furthermore, the analysis of the potential GH component allowed the distinction of clear GH patterns. Some of the GH activities, and their link with the two subspecies under study, are further discussed. Overall, our in silico analysis poses some questions about the suitability of considering the GH activities of B. longum subsp. longum and B. longum subsp. infantis to gain insight into the characterization and classification of these two subspecies with probiotic interest., The research included in the present work was funded by the grants AGL2016-78311-R (funded by AEI/FEDER, UE), RTI2018-095021-J-I00 (funded by MCIU/AEI/FEDER, UE), and IDI/2018/000236 (funded by PCTI Gobierno del Principado de Asturias/FEDER, UE). This study was supported by the Consellería de Educación, Universidades e Formación Profesional (Xunta de Galicia) under the scope of the strategic funding of ED431C2018/55-GRC Competitive Reference Group, the “Centro singular de investigación de Galicia” (accreditation 2019-2022) and the European Union (European Regional Development Fund—ERDF)-Ref. ED431G2019/06, and the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UIDB/04469/2020 unit and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by the European Regional Development Fund under the scope of Norte2020—Programa Operacional Regional do Norte., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In silico and functional analyses of immunomodulatory peptides encrypted in the human gut metaproteome

  • Cambeiro-Pérez, Noelia
  • Hidalgo-Cantabrana, Claudio
  • Moro-García, Marco A.
  • Blanco-Míguez, Aitor
  • Fdez-Riverola, Florentino
  • Riestra, Sabina
  • Lourenço, Anália
  • Alonso-Arias, Rebeca
  • Margolles Barros, Abelardo
  • Martínez-Carballo, Elena
  • Sánchez García, Borja
This work supports the massive presence of potential immunomodulatory peptides in the human gut metaproteome. These peptides were identified through the MAHMI database as potentially anti-inflammatory, and sixteen of them synthesized for characterize their mechanism of action. From them, peptide HM14 was encrypted in an extracellular protein produced by Bifidobacterium longum, a common member of the human microbiota, and displayed the highest anti-inflammatory capability. Molecular mechanism of action of HM14 pointed to a specific interaction between this immunomodulatory peptide and antigen presenting cells, which resulted in a higher formation of iTreg cells. Moreover, HM14 was effective in decreasing pro-inflammatory parameters in PBMCs isolated from a cohort of Crohn’s patients. Finally, non-targeted metabolomics confirmed the ability of HM14 to modulate the metabolic activity of PBMCs to fulfil its energy and biosynthetic requirements. Overall, our combined in silico/multiomics approach supports the human gut metaproteome as a source for immunomodulatory peptides., Our work is supported by the Spanish “Programa Estatal de Investigación. Desarrollo e Innovación Orientada a los Retos de la Sociedad” (grants AGL2013-44761-P and AGL2016-78311-R); the Asociación Española Contra el Cancer (“Obtención de péptidos bioactivos contra el Cáncer Colo-Rectal a partir de secuencias genéticas de microbiomas intestinales”, Grant PS-2016), by the Asturias Regional Plan I + D + i for research groups (FYCYT-IDI/2018/000236) and by the Autonomic “Investigadores Emerxentes do Sistema Universitario de Galicia” (Grant EM2014/046). This work was partially supported by the Consellería de Educación. Universidades e Formación Profesional (Xunta de Galicia) under the scope of the strategic funding of ED431C2018/55-GRC Competitive Reference Group., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The extracellular proteins of Lactobacillus acidophilus DSM 20079T display anti-inflammatory effect in both in piglets, healthy human donors and Crohn's Disease patients

  • Hidalgo-Cantabrana, Claudio
  • Moro-García, Marco A.
  • Blanco-Míguez, Aitor
  • Fdez-Riverola, Florentino
  • Oliván, Mamen
  • Royo, Luis J.
  • Riestra, Sabino
  • Margolles Barros, Abelardo
  • Lourenço, Anália
  • Alonso-Arias, Rebeca
  • Sánchez García, Borja
Lactobacillusgenus includes both probiotic and representative strains of the human gut microbiota. Independentstudies have reported on the anti-inflammatory properties of differentLactobacillusstrains, although we are farfrom understanding the underlying molecular interplay. In this work we show that a daily administration ofLactobacillus acidophilusDSM20079T(DSM20079) to healthy piglets resulted in plasmatic increases of the anti-inflammatory IL10, whilst IL12 and the pro-inflammatory ratio IL12+TNFα/IL10 decreased. The extracellularprotein fraction of DSM20079 was identified as the responsible for the crosstalk interaction that elicited thesetolerogenic effects. This strain was able to activate innate immune pathways in dendritic cells and to decreasethe production of pro-inflammatory cytokines in both CD4+/CD8+T cell subsets in healthy donors and inCrohn’s Disease patients. The tolerogenic effect exerted by the extracellular proteins of this strain suggests theirpotential use as coadjutant for therapeutic applications targeting chronic inflammatory illnesses, Our work is supported by the Spanish“Programa Estatal deInvestigación, Desarrollo e Inovación Orientada a los Retos de laSociedad”(grant AGL2016-78311-R); the Asociación Española Contra el Cancer (“Obtención de péptidos bioactivos contra el Cáncer Colo-Rectal a partir de secuencias genéticas de microbiomas intestinales”,Grant PS-2016) and by the Asturias Regional Plan I+D+i for researchgroups (FYCYT-IDI/2018/000236). This study was also supported bythe Portuguese cc (FCT) under thescope of the strategic funding of UID/BIO/04469/2013 unit andCOMPETE 2020 (POCI-01-0145-FEDER006684). SING group thanksCITI (Centro de Investigación, Transferencia e Innovación) fromUniversity of Vigo for hosting its IT infrastructure. LJR was supportedby the Principado de Asturias, PCTI 2018–2020 (GRUPIN: IDI2018-000237) and FEDER. This work was partially supported by the Consellería de Educación, Universidades e Formación Profesional(Xunta de Galicia) under the scope of the strategic funding ofED431C2018/55-GRC Competitive Reference Group., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Apple pomaces derived from mono-varietal Asturian ciders production are potential source of pectins with appealing functional properties

  • Calvete-Torre, Inés
  • Muñoz-Almagro, Nerea
  • Pacheco, M. Teresa
  • Antón, María José
  • Dapena, Enrique
  • Ruíz García, Lorena
  • Margolles Barros, Abelardo
  • Villamiel, Mar
  • Moreno, F. Javier
Comprehensive chemical characterization of nine mono-varietal apple pomaces obtained from the production of ciders with PDO is described. They were rich in essential minerals, fibers (35–52.9 %), and polyphenols. High levels in GalA (11.8–21.6 %), revealed the suitability of these apple pomaces as efficient sources of pectins. Extracted pectins showed high variability in monomer composition, with degrees of methylesterification, strongly associated with pectins functional properties, ranging from 58 to 88 %. For a subset of apple pomace varieties, pectin extraction was accomplished by conventional acid heat treatment or ultrasound. Despite ultrasound-assisted extraction did not improve pectin yield, it minimized levels of “non-pectin” components as revealed by the low content of Glc/Man, leading to the obtainment of high-purity pectin. Our work highlights the key role played by the selection of the apple variety to streamline the potential food applications (gelling/thickening agents or prebiotics) of the extracted pectins that largely depend on their structural features., The research performed was funded by the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 818368 (MASTER), the grants from MICINN AGL2016-78311-R and AGL2017-84614-C2-1-R, and the grants from the Spanish State Research Agency RTI2018-095021-J-I00 and RTA2017-00102-C03-01 (funded by MCIU/AEI/FEDER, UE).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Vegetable waste and by-products to feed a healthy gut microbiota: Current evidence, machine learning and computational tools to design novel microbiome-targeted foods

  • Sabater, Carlos
  • Calvete-Torre, Inés
  • Villamiel, Mar
  • Moreno, F. Javier
  • Margolles Barros, Abelardo
  • Ruíz García, Lorena
[Background] Food waste management is a key issue to global food security and friendly environmental governance. Worldwide, one-third of food produced for human consumption is lost or wasted along the food supply chain, primary production and food processing representing the most significant loses. Therefore, the need to achieve zero waste production schemes is becoming a priority to meet Sustainable Development Goals. Increasing evidence points towards vegetable food waste as a rich source of a wide array of carbohydrate structures and fibres providing the opportunity to identify and develop alternative approaches to valorize agro-food waste., [Scope and approach] This review describes the valorization of vegetable waste and by-products via production of (novel) substrates targeted to gut microbiota modulation, emphasizing the importance of raw materials and structural-functional properties of carbohydrates. Furthermore, we propose a novel framework for the rational selection of vegetable sources with potential prebiotic activity, based on machine learning and other computational tools applied to available literature and public database information., [Key findings and conclusions] Integration of the body of knowledge within the field of vegetable food waste valorization, from different perspectives, allows a rational selection of carbohydrate-based substrates with promising prebiotic activities. By exploring the interactions among dietary fibre and gut microbial ecosystems using computational tools fed with structural, functional and genomic data, we can identify substrates with potential to selectively stimulate gut commensals, in agreement with experimental evidence. Our approach establishes a new framework that can be extended to a wide range of commensal microbes and carbohydrate structures., The work in our research groups was funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No 818368 (MASTER), and the grants RTI 2018-095021-J-I00 (funded by (MCIU/AEI/FEDER, UE), AGL 2017-84614-C2-1-R and AGL 2016-78311-R (funded by (MINECO/AEI/FEDER, UE). Carlos Sabater acknowledges his Postdoctoral research contract funded by the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) and Postdoctoral research contract Juan de la Cierva-Formación from Spanish Ministry of Science and Innovation (FJC 2019-042125-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel methods of microbiome analysis in the food industry

  • Sabater, Carlos
  • Cobo-Díaz, José F.
  • Álvarez-Ordóñez, Avelino
  • Ruas-Madiedo, Patricia
  • Ruíz García, Lorena
  • Margolles Barros, Abelardo
The study of the food microbiome has gained considerable interest in recent years, mainly due to the wide range of applications that can be derived from the analysis of metagenomes. Among these applications, it is worth mentioning the possibility of using metagenomic analyses to determine food authenticity, to assess the microbiological safety of foods thanks to the detection and tracking of pathogens, antibiotic resistance genes and other undesirable traits, as well to identify the microorganisms responsible for food processing defects. Metataxonomics and metagenomics are currently the gold standard methodologies to explore the full potential of metagenomes in the food industry. However, there are still a number of challenges that must be solved in order to implement these methods routinely in food chain monitoring, and for the regulatory agencies to take them into account in their opinions. These challenges include the difficulties of analysing foods and food-related environments with a low microbial load, the lack of validated bioinformatics pipelines adapted to food microbiomes and the difficulty of assessing the viability of the detected microorganisms. This review summarizes the methods of microbiome analysis that have been used, so far, in foods and food-related environments, with a specific focus on those involving Next-Generation Sequencing technologies., The work in our research groups was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 818368 (MASTER), and the grants RTI2018-095021-J-I00 (funded by (MCIU/AEI/FEDER, UE), AGL2016-78085-P and AGL2016-78311-R (funded by (MINECO/AEI/FEDER, UE). Carlos Sabater acknowledges his Postdoctoral research contract funded by the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) and Postdoctoral research contract Juan de la Cierva-Formación from Spanish Ministry of Science and Innovation (FJC2019-042125-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A machine learning approach to study glycosidase activities from bifidobacterium

  • Sabater, Carlos
  • Ruíz García, Lorena
  • Margolles Barros, Abelardo
This study aimed to recover metagenome-assembled genomes (MAGs) from human fecal samples to characterize the glycosidase profiles of Bifidobacterium species exposed to different prebi-otic oligosaccharides (galacto-oligosaccharides, fructo-oligosaccharides and human milk oligosac-charides, HMOs) as well as high-fiber diets. A total of 1806 MAGs were recovered from 487 infant and adult metagenomes. Unsupervised and supervised classification of glycosidases codified in MAGs using machine-learning algorithms allowed establishing characteristic hydrolytic profiles for B. adolescentis, B. bifidum, B. breve, B. longum and B. pseudocatenulatum, yielding classification rates above 90%. Glycosidase families GH5 44, GH32, and GH110 were characteristic of B. bifidum. The presence or absence of GH1, GH2, GH5 and GH20 was characteristic of B. adolescentis, B. breve and B. pseudocatenulatum, while families GH1 and GH30 were relevant in MAGs from B. longum. These characteristic profiles allowed discriminating bifidobacteria regardless of prebiotic exposure. Correlation analysis of glycosidase activities suggests strong associations between glycosidase families comprising HMOs-degrading enzymes, which are often found in MAGs from the same species. Mathematical models here proposed may contribute to a better understanding of the carbohydrate metabolism of some common bifidobacteria species and could be extrapolated to other microorganisms of interest in future studies., The work in our research groups was funded by the grants RTI2018-095021-J-I00 (funded by (MCIU/AEI/FEDER, UE) and AGL2016-78311-R (funded by (MINECO/AEI/FEDER, UE).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Differential effects of western and mediterranean-type diets on gut microbiota: A metagenomics and metabolomics approach

  • Barber, Claudia
  • Mego, Marianela
  • Sabater, Carlos
  • Vallejo, Fernando
  • Bendezu, Rogger Alvaro
  • Masihy, Marcela
  • Guarner, Francisco
  • Espín de Gea, Juan Carlos
  • Margolles Barros, Abelardo
  • Azpiroz, Fernando
Our aim was to determine the effect of diet on gut microbiota, digestive function and sensations, using an integrated clinical, metagenomics and metabolomics approach. We conducted a cross-over, randomised study on the effects of a Western-type diet versus a fibre-enriched Mediterranean diet. In 20 healthy men, each diet was administered for 2 weeks preceded by a 2-week washout diet. The following outcomes were recorded: (a) number of anal gas evacuations; (b) digestive sensations; (c) volume of gas evacuated after a probe meal; (d) colonic content by magnetic resonance imaging; (e) gut microbiota taxonomy and metabolic functions by shotgun sequencing of faecal samples; (f) urinary metabolites using untargeted metabolomics. As compared to a Western diet, the Mediterranean diet was associated with (i) higher number of anal gas evacuations, (ii) sensation of flatulence and borborygmi, (iii) larger volume of gas after the meal and (iv) larger colonic content. Despite the relatively little difference in microbiota composition between both diets, microbial metabolism differed substantially, as shown by urinary metabolite profiles and the abundance of microbial metabolic pathways. The effects of the diet were less evident in individuals with robust microbiotas (higher beta-diversity). To conclude, healthy individuals tolerate dietary changes with minor microbial modifications at the composition level but with remarkable variation in microbial metabolism., The present study was supported by the projects SAF 2016-76648-R (Ministerio de Economia y Competitividad, Dirección General de Investigación Científica y Técnica, Spain), PID2019- 103914RB-I00 (Ministerio de Ciencia e Innovación, Spain), AGL2016-78311-R (Ministerio de Ciencia e Innovación, Spain) and FJC2019-042125-I (Ministerio de Ciencia e Innovación, Spain). Ciberehd is funded by the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Precision modification of the human gut microbiota targeting surface-associated proteins

  • Marcos-Fernández, Raquel
  • Ruíz García, Lorena
  • Blanco-Míguez, Aitor
  • Margolles Barros, Abelardo
  • Sánchez García, Borja
This work describes a new procedure that allows the targeted modification of the human gut microbiota by using antibodies raised against bacterial surface-associated proteins specific to the microorganism of interest. To this end, a polyclonal antibody recognising the surface-associated protein Surface Layer Protein A of Lactobacillus acidophilus DSM20079 was developed. By conjugating this antibody with fluorescent probes and magnetic particles, we were able to specifically identify this bacterium both in a synthetic, and in real gut microbiotas by means of a flow cytometry approach. Further, we demonstrated the applicability of this antibody to deplete complex human gut microbiotas from L. acidophilus in a single step. L. acidophilus was found to interact with other bacteria both in synthetic and in real microbiotas, as reflected by its concomitant depletion together with other species. Further optimization of the procedure including a trypsin step enabled to achieve the selective and complete isolation of this species. Depleting a single species from a gut microbiota, using antibodies recognizing specific cell surface elements of the target organism, will open up novel ways to tackle research on the specific immunomodulatory and metabolic contributions of a bacterium of interest in the context of a complex human gut microbiota, including the investigation into therapeutic applications by adding/depleting a key bacterium. This represents the first work in which an antibody/flow-cytometry based application enabled the targeted edition of human gut microbiotas, and represents the basis for the design of precision microbiome-based therapies., Our work is supported by the Spanish "Programa Estatal de Investigacian, Desarrollo e Inovacion Orientada a los Retos de la Sociedad" (grant AGL2016-78311-R and contract BES-2017-080978, funded by AEI/FEDER, UE), the Asociación Española Contra el Cáncer (AECC; Grant PS-2016) and by the Asturias Regional Plan I + D + i for research groups (FICYT-IDI/2018/000236, funded by PCTI Gobierno del Principado de Asturias/FEDER, UE).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Arabinoxylan and Pectin Metabolism in Crohn’s Disease Microbiota: An In Silico Study

  • Sabater, Carlos
  • Calvete-Torre, Inés
  • Ruíz García, Lorena
  • Margolles Barros, Abelardo
Inflammatory bowel disease is a chronic disorder including ulcerative colitis and Crohn’s disease (CD). Gut dysbiosis is often associated with CD, and metagenomics allows a better understanding of the microbial communities involved. The objective of this study was to reconstruct in silico carbohydrate metabolic capabilities from metagenome-assembled genomes (MAGs) obtained from healthy and CD individuals. This computational method was developed as a mean to aid rationally designed prebiotic interventions to rebalance CD dysbiosis, with a focus on metabolism of emergent prebiotics derived from arabinoxylan and pectin. Up to 1196 and 1577 MAGs were recovered from CD and healthy people, respectively. MAGs of Akkermansia muciniphila, Barnesiella viscericola DSM 18177 and Paraprevotella xylaniphila YIT 11841 showed a wide range of unique and specific enzymes acting on arabinoxylan and pectin. These glycosidases were also found in MAGs recovered from CD patients. Interestingly, these arabinoxylan and pectin degraders are predicted to exhibit metabolic interactions with other gut microbes reduced in CD. Thus, administration of arabinoxylan and pectin may ameliorate dysbiosis in CD by promoting species with key metabolic functions, capable of cross-feeding other beneficial species. These computational methods may be of special interest for the rational design of prebiotic ingredients targeting at CD, The work in our research groups was funded by the grants RTI2018-095021-J-I00 (funded by (MCIU/AEI/FEDER, UE) and AGL2016-78311-R (funded by (MINECO/AEI/FEDER, UE). Acknowledgments: Carlos Sabater acknowledges his Postdoctoral research contract funded by the Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) and Postdoctoral research contract Juan de la Cierva-Formación from Spanish Ministry of Science and Innovation (FJC2019-042125-I).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effect of Resistant Dextrin on Intestinal Gas Homeostasis and Microbiota

  • Barber, Claudia
  • Sabater, Carlos
  • Ávila-Gálvez, María Ángeles
  • Vallejo, Fernando
  • Bendezu, Rogger Alvaro
  • Guérin-Deremaux, Laetitia
  • Guarner, Francisco
  • Espín de Gea, Juan Carlos
  • Margolles Barros, Abelardo
  • Azpiroz, Fernando
Previous studies have shown that a resistant dextrin soluble fibre has prebiotic properties with related health benefits on blood glucose management and satiety. Our aim was to demonstrate the effects of continuous administration of resistant dextrin on intestinal gas production, digestive sensations, and gut microbiota metabolism and composition. Healthy subjects (n = 20) were given resistant dextrin (14 g/d NUTRIOSE®, Roquette Frères, Lestrem, France) for four weeks. Outcomes were measured before, at the beginning, end, and two weeks after administration: anal evacuations of gas during daytime; digestive perception, girth, and gas production in response to a standard meal; sensory and digestive responses to a comfort meal; volume of colonic biomass by magnetic resonance; taxonomy and metabolic functions of fecal microbiota by shotgun sequencing; metabolomics in urine. Dextrin administration produced an initial increase in intestinal gas production and gas-related sensations, followed by a subsequent decrease, which magnified after discontinuation. Dextrin enlarged the volume of colonic biomass, inducing changes in microbial metabolism and composition with an increase in short chain fatty acids-producing species and modulation of bile acids and biotin metabolism. These data indicate that consumption of a soluble fibre induces an adaptative response of gut microbiota towards fermentative pathways with lower gas production., This work was supported by a grant from Roquette. The research activities were supported in part by the projects PID2021-122295OB-I00 (Ministerio de Ciencia e Innovación, Spain), PID2019-103914RB-I00 (Ministerio de Ciencia e Innovación, Spain), AGL2016-78311-R (Ministerio de Ciencia e Innovación, Spain) and FJC2019-042125-I (Ministerio de Ciencia e Innovación, Spain). Ciberehd is funded by the Instituto de Salud Carlos III.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Arabinoxylan-based substrate preferences and predicted metabolic properties of Bifidobacterium longum subspecies as a basis to design differential media

  • Calvete-Torre, Inés
  • Sabater, Carlos
  • Delgado, Susana
  • Ruas-Madiedo, Patricia
  • Rupérez-García, Alicia
  • Montilla, Antonia
  • Moreno, F. Javier
  • Margolles Barros, Abelardo
  • Ruíz García, Lorena
Arabinoxylan (AX) and arabinoxylo-oligosaccharides (AXOS) derived therefrom are emergent prebiotics with promising health promoting properties, likely linked to its capacity to foster beneficial species in the human gut. Bifidobacteria appear to be one taxa that is frequently promoted following AX or AXOS consumption, and that is known to establish metabolic cross-feeding networks with other beneficial commensal species. Therefore, probiotic bifidobacteria with the capability to metabolize AX-derived prebiotics represent interesting candidates to develop novel probiotic and synbiotic combinations with AX-based prebiotics. In this work we have deepen into the metabolic capabilities of bifidobacteria related to AX and AXOS metabolization through a combination of in silico an in vitro tools. Both approaches revealed that Bifidobacterium longum and, particularly, B. longum subsp. longum, appears as the better equipped to metabolize complex AX substrates, although other related subspecies such as B. longum subsp. infantis, also hold some machinery related to AXOS metabolization. This correlates to the growth profiles exhibited by representative strains of both subspecies in AX or AXOS enriched media. Based on these results, we formulated a differential carbohydrate free medium (CFM) supplemented with a combination of AX and AXOS that enabled to recover a wide diversity of Bifidobacterium species from complex fecal samples, while allowing easy discrimination of AX metabolising strains by the appearance of a precipitation halo. This new media represent an appealing alternative to isolate novel probiotic bifidobacteria, rapidly discriminating their capacity to metabolize structurally complex AX-derived prebiotics. This can be convenient to assist formulation of novel functional foods and supplements, including bifidobacterial species with capacity to metabolize AX-derived prebiotic ingredients., The work in our research groups was funded by the grants from the Spanish State Research Agency RTI2018-095021-J-I00, AGL2016-78311-R and AGL 2017-84614-C2-1-R (funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”), PID2019-104546RB-100 (funded by MCIN/ AEI /10.13039/501100011033), and TED2021-131541B-100 funded by MCIN/AEI/10.13039/501100011033 and Europe Union "NextGenerationEU"/PRTR. We also thank the grant AYUD-2021-50910 from the autonomic Government of Principado de Asturias (FICYT, supported by FEDER), CSIC for funding this research with the grant PIE-201970E019, and grant 101060130, funded by HORIZON-WIDERA-2021-ACCESS-02. CS is a postdoctoral researcher supported by the Juan de la Cierva-Formación Postdoctoral Trainee Program from MICINN, the Spanish Ministry of Science and Innovation (FJC2019-042125-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeted depletion of pks+ bacteria from a fecal microbiota using specific antibodies

  • Blanco-Míguez, Aitor
  • Marcos-Fernández, Raquel
  • Guadamuro, Lucía
  • Fernández Riverola, Florentino
  • Cubiella, Joaquín
  • Lourenço, Anália
  • Margolles Barros, Abelardo
  • Sánchez García, Borja
The pks island is one of the most prevalent pathogenicity islands among the Escherichia coli strains that colonize the colon of colorectal carcinoma (CRC) patients. This pathogenic island encodes the production of a nonribosomal polyketide-peptide named colibactin, which induces double-strand breaks in DNA molecules. Detection or even depletion of this pks-producing bacteria could help to understand the role of these strains in the context of CRC. In this work, we performed a large-scale in silico screening of the pks cluster in more than 6,000 isolates of E. coli. The results obtained reveal that not all the pks-detected strains could produce a functional genotoxin and, using antibodies against pks-specific peptides from surface cell proteins, a methodology for detection and depletion of pks+ bacteria in gut microbiotas was proposed. With our method, we were able to deplete a human gut microbiota of this pks+ strains, opening the door to strain-directed microbiota modification and intervention studies that allow us to understand the relation between these genotoxic strains and some gastrointestinal diseases. IMPORTANCE The human gut microbiome has also been hypothesized to play a crucial role in the development and progression of colorectal carcinoma (CRC). Between the microorganisms of this community, the Escherichia coli strains carrying the pks genomic island were shown to be capable of promoting colon tumorigenesis in a colorectal cancer mouse model, and their presence seems to be directly related to a distinct mutational signature in patients suffering CRC. This work proposes a novel method for the detection and depletion of pks-carrying bacteria in human gut microbiotas. In contrast to methods based on probes, this methodology allows the depletion of low-abundance bacterial strains maintaining the viability of both targeted and non-targeted fractions of the microbiota, allowing the study of the contribution of these pks-carrying strains to different diseases, such as CRC, and their role in other physiological, metabolic or immune processes., This work was supported by the Spanish “Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad” (Grant AGL2016-78311-R and contract BES-2017-080978, funded by AEI/FEDER, UEAGL2016-78311-R); the Asociación Española Contra el Cáncer (“Obtención de péptidos bioactivos contra el Cáncer Colo-Rectal a partir de secuencias genéticas de microbiomas intestinales”, Grant PS-2016 and by the Asturias Regional Plan I+D+i for research groups (FICYT-IDI/2018/000236, funded by PCTI Gobierno del Principado de Asturias/FEDER, UE). This study was also supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER006684). SING group thanks CITI (Centro de Investigación, Transferencia e Innovación) from the University of Vigo for hosting its IT infrastructure. A.B.M. was supported by a predoctoral contract from the AECC. Borja Sánchez and Abelardo Margolles are on the scientific board and are co-founders of Microviable Therapeutics SL. The other authors have no competing interests. Results presented in this paper are protected under European Patent EP19383077 (WO2021110833A1 and US20230029322A1; Tools and methods to detect and isolate colibactin producing bacteria)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Convergence of flow cytometry and bacteriology. Current and future applications: a focus on food and clinical microbiology

  • Marcos-Fernández, Raquel
  • Sánchez García, Borja
  • Ruíz García, Lorena
  • Margolles Barros, Abelardo
Since its development in the 1960s, flow cytometry (FCM) was quickly revealed a powerful tool to analyse cell populations in medical studies, yet, for many years, was almost exclusively used to analyse eukaryotic cells. Instrument and methodological limitations to distinguish genuine bacterial signals from the background, among other limitations, have hampered FCM applications in bacteriology. In recent years, thanks to the continuous development of FCM instruments and methods with a higher discriminatory capacity to detect low-size particles, FCM has emerged as an appealing technique to advance the study of microbes, with important applications in research, clinical and industrial settings. The capacity to rapidly enumerate and classify individual bacterial cells based on viability facilitates the monitoring of bacterial presence in foodstuffs or clinical samples, reducing the time needed to detect contamination or infectious processes. Besides, FCM has stood out as a valuable tool to advance the study of complex microbial communities, or microbiomes, that are very relevant in the context of human health, as well as to understand the interaction of bacterial and host cells. This review highlights current developments in, and future applications of, FCM in bacteriology, with a focus on those related to food and clinical microbiology., This work was supported by the National Grant AGL2016-78311-R funded by MCIN/ AEI/ 10.13039/501100011033/ andERDF A way of making Europe). LR has received fundingfrom the Spanish State Research Agency [Grant RTI2018-095021-J-100 funded by MCIN/ AEI /10.13039/501100011033/and by ERDF A way of making Europe]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile

  • Marcos-Fernández, Raquel
  • Riestra, Sabino
  • Alonso-Arias, Rebeca
  • Ruíz García, Lorena
  • Sánchez, Borja
  • Margolles Barros, Abelardo
Faecalibacterium represents one of the most abundant bacterial groups in the human intestinal microbiota of healthy adults and can represent more than 10% of the total bacterial population, Faecalibacterium prausnitzii being the only recognized species up to the past year. Reduction in the abundance of F. prausnitzii in the human gut has been linked to several human disorders, such as Crohn's disease. In this study, we developed a strategy to modify the relative abundance of F. prausnitzii in fecal microbiotas as a means of evaluating its contribution to the immunomodulatory effect of intestinal microbiotas with different F. prausnitzii contents using a peripheral blood mononuclear cell (PBMC) model. We used a polyclonal antibody against the surface of F. prausnitzii M21 to capture the bacterium from synthetic and human fecal microbiotas using immunoseparation techniques. As a proof-of-principle study, the levels of immunomodulation exerted by microbiotas of healthy donors (HDs) with different relative abundances of F. prausnitzii, achieved with the above-mentioned immunoseparation technique, were evaluated in a PBMC model. For this purpose, PBMCs were cocultivated with the modified microbiotas or a pure culture of F. prausnitzii and, subsequently, the microbiota of Crohn's donors was added to the coculture. The cytokine concentration was determined, showing that our experimental model supports the anti-inflammatory effects of this bacterium. IMPORTANCE There is increasing interest in deciphering the contribution of gut microbiota species to health and disease amelioration. The approach proposed herein provides a novel and affordable strategy to probe deeply into microbiota-host interactions by strategically modifying the relative abundance of specific gut microbes, hence facilitating the study of their contribution to a given trait of the microbiota., Our work is supported by the Spanish Agencia Estatal de Investigación (proyecto AGL2016-78311-R financiado por MCIN/AEI/10.13039/501100011033/y por FEDER Una manera de hacer Europa), the Asociación Española Contra el Cáncer (AECC Grant PS-2016) and by the Plan Regional de I1D1i del Principado de Asturias (AYUD/2021/50910, funded by PCTI Gobierno del Principado de Asturias/FEDER, UE). L.R. was supported by RTI2018-095021-J-I00 (financiado por MCIN/ AEI /10.13039/501100011033/ y por FEDER Una manera de hacer Europa). We also thank the Agencia Estatal de Investigación for granting research contract BES-2017-080978., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A methyl esterase from Bifidobacterium longum subsp. longum reshapes the prebiotic properties of apple pectin by triggering differential modulatory capacity in faecal cultures

  • Calvete-Torre, Inés
  • Sabater, Carlos
  • Muñoz-Almagro, Nerea
  • Campelo, Ana B.
  • Moreno, F. Javier
  • Margolles Barros, Abelardo
  • Ruíz García, Lorena
Pectin structures have received increasing attention as emergent prebiotics due to their capacity to promote beneficial intestinal bacteria. Yet the collective activity of gut bacterial communities to cooperatively metabolize structural variants of this substrate remains largely unknown. Herein, the characterization of a pectin methylesterase, BpeM, from Bifidobacterium longum subsp. longum, is reported. The purified enzyme was able to remove methyl groups from highly methoxylated apple pectin, and the mathematical modelling of its activity enabled to tightly control the reaction conditions to achieve predefined final degrees of methyl-esterification in the resultant pectin. Demethylated pectin, generated by BpeM, exhibited differential fermentation patterns by gut microbial communities in in vitro mixed faecal cultures, promoting a stronger increase of bacterial genera associated with beneficial effects including Lactobacillus, Bifidobacterium and Collinsella. Our findings demonstrate that controlled pectin demethylation by the action of a B. longum esterase selectively modifies its prebiotic fermentation pattern, producing substrates that promote targeted bacterial groups more efficiently. This opens new possibilities to exploit biotechnological applications of enzymes from gut commensals to programme prebiotic properties., We thank the projects MICINNAGL2016-78311-R, RTI2018-095021-J-I00, PID2021-123862OB-100 and PID2022-141737OB-I00, funded by MCIN/AEI/ 10.13039/501100011033/ and by ERDF A way of making Europe; and AYUD-2021-50910 from the autonomic Government of Principado de Asturias (FICYT, supported by FEDER). Carlos Sabater was the recipient of a Juan de la Cierva-Formación postdoctoral contract from MICINN, the Spanish Ministry of Science and Innovation (FJC2019-042125-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effects of a (poly)phenol-rich berry mix on gas production in healthy individuals: An integrated clinical, metagenomic, and metabolomic proof-of-concept study

  • Barber, Claudia
  • Sabater, Carlos
  • Frutos, María Dolores
  • Vallejo, Fernando
  • Guyonnet, Denis
  • Daniel, Noëmie
  • Guarner, Francisco
  • Espín de Gea, Juan Carlos
  • Margolles Barros, Abelardo
  • Azpiroz, Fernando
Dietary (poly)phenols are metabolized by intestinal microbiota, but their potential effect on intestinal gas production and gas-reated symptoms remain uncertain. The aim of this study was to correlate gas production, digestive sensations, gut microbiota composition, and metabolites in urine and feces upon (poly)phenols consumption. Twenty-three healthy subjects consumed a (poly)phenol-rich berry mix for 18 days. The (poly)phenol-rich mix initially increased anal gas evacuation and induced gas-related sensations, which reverted by 18 days of dietary administration, indicating that they were metabolized and induced an adaptation of the microbiota. Upon consumption, microbiota composition adapted, exhibiting significant correlations between some taxa, bile acids, and digestive sensations, like L. pectinoschiza, positively associated with digestive well-being. Notably, the steroid-like metabolite cortolone decreased 7-fold (p < 0.001), and the bile acid 7-ketodeoxycholic acid decreased 5-fold (p < 0.001) in the urine. These preliminary data suggest that consumption of a (poly)phenol-rich berry mix induces an adaptation of the gut microbiota with beneficial effects on gas-related sensations, This work was supported by a grant from Symrise AG (Diana Food Inc.). The research activities were partially supported by the projects PID2021-122295OB-I00, PID2019-103914RB-I00, and AGL2016-78311-R (Ministry of Science and Innovation, MICIN, AEI /https://doi.org/10.13039/501100011033, Spain), and by FJC2019-042125-I (MICIN). Ciberehd is funded by the Instituto de Salud Carlos III, Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Differential effects of western and mediterranean-type diets on gut microbiota, a metagenomics and metabolomics approach

  • Barber Caselles, Claudia|||0000-0003-4711-2731
  • Mego Silva, Marianela
  • Sabater, Carlos|||0000-0002-6098-895X
  • Vallejo, Fernando|||0000-0003-3343-6479
  • Bendezú García, Rogger Álvaro
  • Masihy, Marcela
  • Guarner, Francisco|||0000-0002-4051-0836
  • Espín, Juan Carlos|||0000-0002-1068-8692
  • Margolles, Abelardo
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
Our aim was to determine the effect of diet on gut microbiota, digestive function and sensations, using an integrated clinical, metagenomics and metabolomics approach. We conducted a cross-over, randomised study on the effects of a Western-type diet versus a fibre-enriched Mediterranean diet. In 20 healthy men, each diet was administered for 2 weeks preceded by a 2-week washout diet. The following outcomes were recorded: (a) number of anal gas evacuations; (b) digestive sensations; (c) volume of gas evacuated after a probe meal; (d) colonic content by magnetic resonance imaging; (e) gut microbiota taxonomy and metabolic functions by shotgun sequencing of faecal samples; (f) urinary metabolites using untargeted metabolomics. As compared to a Western diet, the Mediterranean diet was associated with (i) higher number of anal gas evacuations, (ii) sensation of flatulence and borborygmi, (iii) larger volume of gas after the meal and (iv) larger colonic content. Despite the relatively little difference in microbiota composition between both diets, microbial metabolism differed substantially, as shown by urinary metabolite profiles and the abundance of microbial metabolic pathways. The effects of the diet were less evident in individuals with robust microbiotas (higher beta-diversity). To conclude, healthy individuals tolerate dietary changes with minor microbial modifications at the composition level but with remarkable variation in microbial metabolism.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effect of Resistant Dextrin on Intestinal Gas Homeostasis and Microbiota

  • Barber Caselles, Claudia|||0000-0003-4711-2731
  • Sabater, Carlos|||0000-0002-6098-895X
  • Ávila-Gálvez, María Ángeles|||0000-0003-2513-1026
  • Vallejo, Fernando|||0000-0003-3343-6479
  • Bendezú García, Rogger Álvaro
  • Guérin-Deremaux, Laetitia
  • Guarner, Francisco|||0000-0002-4051-0836
  • Espín, Juan Carlos|||0000-0002-1068-8692
  • Margolles, Abelardo
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
Previous studies have shown that a resistant dextrin soluble fibre has prebiotic properties with related health benefits on blood glucose management and satiety. Our aim was to demonstrate the effects of continuous administration of resistant dextrin on intestinal gas production, digestive sensations, and gut microbiota metabolism and composition. Healthy subjects (n = 20) were given resistant dextrin (14 g/d NUTRIOSE ®, Roquette Frères, Lestrem, France) for four weeks. Outcomes were measured before, at the beginning, end, and two weeks after administration: anal evacuations of gas during daytime; digestive perception, girth, and gas production in response to a standard meal; sensory and digestive responses to a comfort meal; volume of colonic biomass by magnetic resonance; taxonomy and metabolic functions of fecal microbiota by shotgun sequencing; metabolomics in urine. Dextrin administration produced an initial increase in intestinal gas production and gas-related sensations, followed by a subsequent decrease, which magnified after discontinuation. Dextrin enlarged the volume of colonic biomass, inducing changes in microbial metabolism and composition with an increase in short chain fatty acids-producing species and modulation of bile acids and biotin metabolism. These data indicate that consumption of a soluble fibre induces an adaptative response of gut microbiota towards fermentative pathways with lower gas production.